To investigate the expression of Bcl-2, Bcl-x, Mcl-1, Bax and Bak proteins in human uterine leiomyomas and homologous myometrium during the menstrual cycle and after menopause. The expression of Bcl-2, Bcl-x, Mcl-1, Bax and Bak in leiomyomas (n=24) and myometrial samples (n=22) from women with leiomyomas was measured by immunohistochemistry and Western blot. Measured by immunohistochemistry, a significant difference between leiomyomas and myometrium was observed only for the Bax protein, in tissues obtained from women in the secretory phase of the menstrual cycle. The Bcl-2 staining was more abundant in leiomyomas than in myometrium only in tissues obtained in the proliferative phase of the cycle. Bcl-2 was more abundant in leiomyomas from women of fertile age than in leiomyomas from menopausal women. No significant differences were observed for the Bcl-x or Bak proteins, whereas the Mcl-1 protein was significantly less abundant in secretory phase leiomyomas than in leiomyomas from menopausal women. Western blot analysis based on pools of tissue extracts from the different groups essentially confirmed the data obtained by immunohistochemistry. Bcl-2 family proteins are expressed in leiomyomas and myometrium in different phases related to and influenced by gonadal steroids. These proteins are suggested to interact with each other in the regulation of programmed cell death, apoptosis, but their specific role in growth control of uterine leiomyomas remains to be investigated.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0960-0760(01)00177-7 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Low-Grade Endometrial Stromal Sarcoma: A Case Report of a Rare Uterine Malignancy Mimicking Degenerative Uterine Leiomyoma in a Nulliparous Woman.
Diagnostics (Basel)
December 2024
Department of Radiology, Jeonbuk National University Medical School and Hospital, 20 Geonji-ro, Deokjin-gu, Jeonju 54907, Jeonbuk, Republic of Korea.
Low-grade endometrial stromal sarcoma (LGESS) is a rare uterine malignancy that causes non-specific symptoms which presents more typically in younger women compared to other uterine sarcomas. Preoperative diagnosis of myometrial LGESS is challenging, as it is frequently mistaken for a benign uterine mass, such as a degenerating leiomyoma. Despite its rarity, the imaging findings of LGESS are highly variable, complicating the diagnostic process.
View Article and Find Full Text PDFA case of large uterine cystic adenomyosis outside the uterus after laparoscopic myomectomy: a case report and literature review.
BMC Womens Health
January 2025
Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, No.36 Sanhao Street, Heping District, Shenyang, Liaoning Province, 110004, China.
Background: Uterine cystic adenomyosis is a rare form of focal adenomyosis that is primarily located within the myometrium. In this case report, we present a unique case of adult uterine cystic adenomyosis found outside the uterus following laparoscopic myomectomy.
Case Presentation: The patient was a 36-year-old Chinese woman who had previously undergone laparoscopic surgery at our hospital to remove a 4 cm diameter diameter uterine fibroid six years prior.
Mesothelial Cyst in the Uterine Myometrium: A Rare Localization.
Cureus
December 2024
Department of Obstetrics and Gynecology, Kastamonu Training and Research Hospital, Kastamonu, TUR.
Article Synopsis
- Mesothelial cysts in the uterus are extremely rare; a 41-year-old woman experienced abdominal pain and imaging revealed a cystic mass in her uterus.
- The patient underwent laparoscopic surgery, where a 7 cm cystic lesion was found in the uterine wall.
- Pathological tests confirmed it was a mesothelial cyst, emphasizing that these cysts can resemble other conditions and are best diagnosed through surgical removal and examination.
Loss of PRICKLE1 leads to subfertility, aberrant extracellular matrix, and abnormal myometrial architecture in mice.
Reproduction
December 2024
V Chennathukuzhi, Cell Biology and Physiology, The University of Kansas Medical Center, Kansas City, United States.
Article Synopsis
- Uterine leiomyomas (UL) are common benign tumors affecting over 75% of reproductive-age women, causing symptoms like pelvic pain and reproductive dysfunction, but lack effective long-term treatments, leading to high hysterectomy rates.
- The loss of REST/NRSF in the myometrium has been linked to UL development, and the protein PRICKLE1 is crucial for REST's function and Wnt/PCP signaling, areas that are not fully understood in relation to UL.
- Research involving the deletion of Prickle1 in mouse models showed a UL phenotype with changes in collagen expression and ECM deposition, paving the way for better understanding UL and potential new therapies.
Uterine fibroids show evidence of shared genetic architecture with blood pressure traits.
Pac Symp Biocomput
December 2024
School of Graduate Studies, Department of Microbiology, Immunology and Physiology, Meharry Medical College, Nashville, TN, 37208, Division of Quantitative and Clinical Science, Department of Obstetrics and Gynecology, Data Science Institute, Vanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, TN, 37203, U.S.A.
Uterine leiomyomata (fibroids, UFs) are common, benign tumors in females, having an estimated prevalence of up to 80%. They are fibrous masses growing within the myometrium leading to chronic symptoms like dysmenorrhea, abnormal uterine bleeding, anemia, severe pelvic pain, and infertility. Hypertension (HTN) is a common risk factor for UFs, though less prevalent in premenopausal individuals.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!